Direct AMPK Activation Extends Lifespan Across Multiple Organisms by Over One-Quarter

Researchers demonstrated that directly activating AMPK, a cellular protein that monitors and regulates energy metabolism, extended lifespan by more than 25% in yeast, nematode worms, and fruit flies. The drug compound 991 targets AMPK directly, triggering energy-conservation mechanisms that shift cells from costly protein production and fat storage toward breakdown of existing fuel reserves. These findings across evolutionarily distant organisms suggest that AMPK activation warrants investigation as a potential longevity intervention in mammals.

AMPK functions as a metabolic gatekeeper, monitoring energy availability within cells and triggering adaptive responses when fuel becomes scarce. When activated, it redirects cellular resources away from energy-intensive processes like protein synthesis and fat accumulation, instead promoting the conversion of existing energy reserves into usable fuel. This mechanism mirrors biological responses to fasting or physical exertion.

The research employed compound 991 as a tool to isolate AMPK's specific effects, circumventing complications from indirect activation methods used by existing medications. By testing this direct activator across three evolutionarily distant organisms—each with substantially different lifespans ranging from weeks to months—researchers gathered evidence suggesting the longevity mechanism may represent a conserved biological principle rather than a species-specific phenomenon.